XML 15 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
Statements of Income (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2018
Dec. 31, 2017
Revenue        
Revenue $ 6,269,405 $ 7,360,789 $ 20,883,386 $ 21,964,689
Cost of sales 1,169,406 1,657,700 3,918,256 4,809,235
Gross profit 5,099,999 5,703,089 16,965,130 17,155,454
Expenses        
Research and development 1,126,975 852,739 3,087,964 2,788,968
Selling, general, and administrative 268,905 313,033 975,114 1,060,757
Total expenses 1,395,880 1,165,772 4,063,078 3,849,725
Income from operations 3,704,119 4,537,317 12,902,052 13,305,729
Interest income 457,204 404,665 1,325,299 1,154,303
Income before taxes 4,161,323 4,941,982 14,227,351 14,460,032
Provision for income taxes 739,918 1,370,380 2,578,287 4,429,780
Net income $ 3,421,405 $ 3,571,602 $ 11,649,064 $ 10,030,252
Net income per share – basic (in dollars per share) $ 0.71 $ 0.74 $ 2.41 $ 2.07
Net income per share – diluted (in dollars per share) 0.71 0.74 2.40 2.07
Cash dividends declared per common share (in dollars per share) $ 1 $ 1 $ 3 $ 3
Weighted average shares outstanding        
Basic (in shares) 4,845,010 4,841,369 4,843,355 4,841,130
Diluted (in shares) 4,850,507 4,847,290 4,850,120 4,846,036
Product [Member]        
Revenue        
Revenue $ 5,991,241 $ 6,448,831 $ 19,916,864 $ 19,718,584
Contract Research and Development [Member]        
Revenue        
Revenue $ 278,164 $ 911,958 $ 966,522 $ 2,246,105